Europe Unlicensed Specials Product Types and Dosage Forms

What Unlicensed Specials Are and Why Product Type Matters

Unlicensed specials are medicines that are made to order, reformulated or imported to meet an individual prescriber's request where no suitable licensed product exists. They form a large part of the Europe unlicensed specials market, and they are best understood as a supply category rather than a single kind of product.

Because the category is defined by how a medicine reaches a patient, product type is the first lens most buyers use. A hospital pharmacist who needs a liquid form of a tablet medicine, a sterile syringe in a non-standard strength or an eye preparation in a particular concentration is asking for very different capabilities, and the supplier universe for each is different.

The product type dimension used in the full report has twelve categories: oral liquid specials, suspensions, solutions, syrups, oral powders, capsules, tablets, topical preparations, sterile specials, injectable specials, ophthalmic specials and dermatology specials. The first four are grouped under oral liquids, the next three are oral solid or powder forms, and the remainder are topical or sterile.

These groupings matter because manufacturing infrastructure differs sharply between them. Oral liquid manufacture needs mixing, filling and stability knowledge. Sterile preparation needs aseptic environments and a different quality system. Topical preparation sits between the two. A supplier strong in one group is not automatically credible in another.

Taken together, these groups also show why a general statement about specials says little. Product type sets the technical difficulty, the likely size of each order and the number of organisations that could realistically supply, and every later segmentation dimension in the report is easier to read once the product type is clear. Readers new to the category should therefore treat product type as the vocabulary of the whole market.

This page describes the category as a commercial segment only and makes no clinical, safety or regulatory claim about any product.

Oral Liquid Specials: Suspensions, Solutions and Syrups

Oral liquid specials are the most recognisable face of the category. Many widely used medicines are marketed only as tablets or capsules, which are unsuitable for young children, for patients who cannot swallow solid forms and for patients who receive medicine through a feeding tube. A liquid presentation of the same active ingredient is then supplied as a special.

Within oral liquids the three main sub-types are suspensions, solutions and syrups. A solution has the active ingredient dissolved in a liquid. A suspension holds undissolved particles dispersed in a liquid and normally needs shaking before use. A syrup is a concentrated sugar-based or similarly viscous liquid that is often chosen for taste and acceptability, particularly for children.

From a market perspective the three sub-types share much of the same manufacturing equipment, but they differ in formulation skill, in the stability information a buyer expects and in how forgiving each is of changes in batch size. This is why oral liquid expertise is one of the benchmarking criteria used in the full report's competitive chapters.

Oral liquids also carry the heaviest repeat demand. Orders for a given strength are often placed again and again for the same patient groups, which makes supply continuity as important as range. Buyers therefore tend to value suppliers that keep a stable portfolio and avoid discontinuing products that depend on small volumes.

The scale of oral liquid demand is also what makes it attractive to both specialised manufacturers and to multinational specialty pharma companies, and it is the product group in which European expansion by UK-focused specialists is most commonly discussed.

Palatability and dosing accuracy are practical points of differentiation within the group. Flavouring, concentration choice and the ability to supply a graduated measuring device or oral syringe along with the bottle influence how readily a hospital ward or a carer can use the product, and these service details often distinguish suppliers whose basic formulations are otherwise similar.

Oral Powders, Capsules and Tablets

Oral powders, capsules and tablets might seem out of place in a category known for liquids, but they appear in unlicensed specials for several reasons. A powder may be supplied in individual sachets or papers to give a dose that no licensed strength provides. A capsule may be prepared in a non-standard strength, or a tablet may be imported from a market where a different presentation is licensed.

Oral powders are often used as an intermediate route: some are supplied as powders for reconstitution by the pharmacy or the patient, which extends shelf life and simplifies transport for products that are unstable once mixed. Capsules suit low-dose, tailored or rare strength requirements. Tablets in the unlicensed category are frequently imports rather than specially made products.

This group is smaller than oral liquids but is commercially relevant because it overlaps most closely with imported unlicensed medicines and reformulated medicines. A buyer looking at a shortage of a licensed tablet will often compare an imported tablet, a reformulated capsule and a special liquid before deciding.

Supplier capability in this group is also more varied. Import specialists and wholesalers are as likely to supply a tablet as a manufacturer is, whereas capsules and powders usually come from manufacturers with encapsulation and powder handling capability.

For the report, the practical point is that product type is not a stand-alone choice. It determines which manufacturing route is realistic, and the route in turn determines how fast a product can reach the patient.

A further reason to treat this group separately is data availability. Because tablets and capsules in the category are frequently imported, buyers often have less information on the exact excipients and the packaging than for a locally made liquid, and product identification and labelling in a different language become a practical part of the purchasing decision.

Topical Preparations and Dermatology Specials

Topical preparations are creams, ointments, gels, lotions and similar products applied to the skin or another external surface. Within the unlicensed category they are supplied as special-order products when a prescriber needs a particular strength, a combination of ingredients or a base that licensed products do not offer.

Dermatology specials are identified separately in the product type dimension because skin conditions generate a steady flow of individually tailored requests. Many are for a specific concentration of an active ingredient in a given base, and prescribers may return to the same specification repeatedly for the same patient.

The commercial structure of topical specials is different from oral liquids. Demand is spread across a larger number of specifications with a smaller volume for each, which suits suppliers that run flexible small batches. Hospital dermatology units and specialist clinics are the typical buyers, along with community pharmacy supplied through wholesalers.

Topical specials also sit close to pharmacy compounding, where preparation is carried out at or near the point of care. The boundary between a pharmacy-prepared item and a manufactured special is one of the segmentation questions the full report addresses.

For buyers, the main selection factors in this group are formulation capability, stability information and the ability to supply small quantities on short lead times, rather than scale. Many of these products are specially made to order, though some are imported, and how special manufacturing and imports are organised shapes how quickly a repeat order can be filled.

Because dermatology and topical requests are so specification-specific, suppliers that publish a clear product range and hold stability data for their most requested strengths are usually the first to be approached by hospital pharmacy teams, and a supplier that can only respond to bespoke requests is less visible to buyers.

Sterile, Injectable and Ophthalmic Specials

Sterile specials are products that must be supplied free of microbial contamination, and they include injectable specials and ophthalmic specials. They form a distinct technical group because the manufacturing environment, equipment and quality system are not the same as those used for oral or topical products.

Injectable specials cover items such as non-standard concentrations, ready-to-administer syringes and bags, and presentations that hospital teams want prepared in advance so that they can be used quickly. Ophthalmic specials cover eye drops and similar preparations in strengths or combinations that licensed products do not provide.

The supplier base for sterile specials is narrower than for oral liquids, because aseptic capability requires significant investment and specialist staff. Hospital preparation units, specialist manufacturers and a small number of larger groups account for most supply, and outsourcing by hospitals to external sterile suppliers is a recurring theme in the report.

Delivery speed is especially important in this group, because many sterile specials have limited shelf life and are needed for named patients on a specific day. Cold-chain handling, short lead times and reliable scheduling therefore weigh heavily in buyer decisions.

In the full report, sterile specials are identified as the product type with the strongest momentum, which is consistent with growing outsourcing, the use of ready-to-use presentations and the effect of shortages of licensed sterile products.

The sterile group also has the clearest overlap with named patient demand and with oncology and rare disease patient groups, since these patients more often need individually adjusted preparations. A supplier that holds aseptic capability and a flexible scheduling model therefore has a position that is difficult for oral liquid specialists to replicate quickly.

How Product Type Connects to Manufacturing and Supply

Product type, manufacturing route and channel form a connected chain. A buyer who knows that a given product is a topical preparation can narrow the supplier list quickly, but the choice among those suppliers then depends on route: whether the product is specially manufactured, reformulated or imported.

The manufacturing routes described elsewhere in the report show that the same product type can be supplied by very different routes, and that is why category-level knowledge of product type is only the first step in sourcing. A buyer comparing a specially made liquid with an imported equivalent is comparing two routes for one product type, with different lead times, documentation and continuity of supply.

The chain also explains where capacity is concentrated. Oral liquids attract the largest number of suppliers, topical products depend on flexible small-batch capacity, and sterile products depend on a few specialised sites. A shortage in one group does not therefore translate into a shortage in another.

Competitive benchmarking in the full report looks at product breadth and oral liquid expertise as separate measures for exactly this reason, and an overview of the companies that supply these product types shows how supplier types align with product groups.

For anyone planning supply, the practical conclusion is to define product type precisely before approaching suppliers, because a vague request such as a liquid or a sterile product hides the formulation, stability and delivery questions that decide who can actually respond.

Finally, because the same product type can move through several channels, buyers are well advised to ask each supplier which channel it normally uses for the product concerned. A manufacturer that sells mainly through wholesalers may offer a different lead time than one that supplies a hospital pharmacy directly, even where the underlying product is identical.